# Does Semaglutide Lower Your Risk From COVID-19 or Flu? | Buy This GLP

What SELECT and a matched health records study found about semaglutide, COVID-19, flu and outcomes after infection.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-lower-your-risk-from-covid-or-flu
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Does Semaglutide Lower Your Risk From COVID-19 or Flu?

A SELECT trial analysis and a matched records study found fewer deaths after infection. The evidence for prevention and treatment is a separate question.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

30-day mortality after a recorded infection · Prior semaglutide above, metformin below · COVID-19 · 0.3% · 0.8% · Influenza · 0.2% · 0.7% · Matched medical records study

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A secondary analysis of the randomized SELECT trial found fewer COVID-19 deaths among semaglutide participants but no reduction in the number who developed COVID-19.
-   A separate records study found lower 30-day mortality after documented COVID-19 or influenza among prior semaglutide users than among matched metformin users.
-   The results do not establish semaglutide as a way to prevent or treat COVID-19 or flu.

## What the randomized SELECT trial found

SELECT randomized 17,604 adults aged 45 or older to weekly semaglutide or placebo. They had established cardiovascular disease and overweight or obesity, without diabetes. The primary question was about major cardiovascular events. In a secondary analysis, COVID-19 occurred at similar rates in the two groups, but fewer participants in the semaglutide group died of COVID-19 (43 versus 65; hazard ratio 0.66, 95% CI 0.44 to 0.96) [\[1\]](https://buythisglp.com/research/do-glp1-drugs-lower-your-risk-from-covid-or-flu#ref-1).

## What can records tell us about flu and COVID-19?

A separate medical records study compared people who were already taking semaglutide after a documented infection with matched metformin users who had no prior GLP-1 treatment. There were 7,092 people per treatment group for COVID-19 and 1,920 per group for flu. Thirty-day all-cause mortality was 0.3% versus 0.8% after COVID-19 (risk ratio 0.39) and 0.2% versus 0.7% after flu (risk ratio 0.29, 95% CI 0.09 to 0.87) [\[2\]](https://buythisglp.com/research/do-glp1-drugs-lower-your-risk-from-covid-or-flu#ref-2).

In each comparison, the difference was about five deaths per 1,000 people with a documented infection, based on the rounded rates. The study matched people on factors including vaccination history and antiviral use. Differences the researchers could not measure, such as frailty or how closely people followed treatment, could still affect the results.

## What the studies leave open

Studies of [GLP-1 drugs and markers of inflammation](https://buythisglp.com/research/do-glp1-drugs-reduce-inflammation) examine a possible explanation for better outcomes. The COVID-19 and influenza studies do not establish which biological changes, if any, account for the observed differences.

Both studies looked at people assigned or treated before infection, so they do not show whether starting semaglutide after getting sick helps.

## Frequently asked

Does semaglutide help prevent COVID-19?

SELECT did not find that semaglutide reduced COVID-19 infections. A separate analysis within that trial found fewer COVID-19 deaths among adults with overweight or obesity and cardiovascular disease assigned semaglutide.

Does semaglutide treat influenza?

The flu study compared prior semaglutide users with prior metformin users after a documented infection. It did not test starting semaglutide as a treatment for flu.

## Sources

1.  \[1\] Scirica BM, et al. (2024). The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial Journal of the American College of Cardiology. [Source](https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007)
2.  \[2\] Matson R, et al. (2026). Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection Biology Methods and Protocols. [PMID 42540132](https://pubmed.ncbi.nlm.nih.gov/42540132/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
